Carolyn Pomerantz files Form 144 to sell 13,542 SCHW shares on NYSE
Rhea-AI Filing Summary
The Charles Schwab Corporation (SCHW) Form 144 notifies the market that Carolyn S. Pomerantz intends to sell 13,542 shares of common stock, scheduled approximately for 08/25/2025 on the NYSE with an aggregate market value shown as $1,302,009.00. The shares were acquired as a gift from Charles R. Schwab on 02/14/2022; the donor originally acquired the stock on 11/26/1986.
The filing also discloses three prior sales by the same seller in the past three months: 24,000 shares sold on each of 06/05/2025, 07/03/2025, and 08/07/2025 with gross proceeds of $2,093,956, $2,198,154, and $2,320,656 respectively. The filer certifies no undisclosed material adverse information.
Positive
- Full compliance disclosure under Rule 144, providing transparency on proposed insider-related sale
- Acquisition provenance provided (gift from Charles R. Schwab, donor acquisition date 11/26/1986), showing clear chain of title
Negative
- Multiple recent sales by the same seller in the past three months (72,000 shares total) could increase share supply and attract investor attention
- Proposed sale value (~$1.3 million) adds to recent sizable disposals, which may be interpreted by some market participants as increased insider sell activity
Insights
TL;DR: Routine Form 144 disclosing proposed sale by an insider-related holder; recent multiple sales increase monitoring interest.
The filing is a standard disclosure of an intended sale under Rule 144 by Carolyn S. Pomerantz of 13,542 SCHW shares valued at roughly $1.3 million for a scheduled sale date of 08/25/2025. Material context includes three prior sales in the past three months totaling 72,000 shares with combined gross proceeds of about $6.6 million, which may be relevant to supply/demand near-term but are disclosed as routine compliance activity. No earnings, guidance, or operational details are included in the filing.
TL;DR: Compliance-focused disclosure showing transfers and sales from a holder with historical family linkage to founder; no governance red flags in form text.
The submission documents that the shares to be sold were received as a gift from Charles R. Schwab in 2022, indicating familial or related-party transfer history; donor acquisition date is 11/26/1986. The signer affirms absence of undisclosed material adverse information. The filing does not allege any regulatory action, executive change, or internal governance event, so it reads as a procedural trading notice rather than a governance disclosure.